June 1-6, 2008 - Algarve, Portugal

Editors:   Barry C. Buckland, Merck & Co., Inc.
  John G. Auniņš, Merck & Co., Inc.
  Paula Marques Alves, ITQB/IBET
  Kathrin U. Jansen, Wyeth Vaccine Research

The articles for these proceedings are not peer-reviewed.

Follow

PDF

VACCINE TECHNOLOGY II: Conference Program, Barry C. Buckland, John G. Auniņš, Paula Marques Alves, and Kathrin U. Jansen (Article)

PDF

Quality Issues: The Good-Enough Vaccine, Philip Minor (Article)

PDF

Towards a Therapeutic Hepatitis C Vaccine – a Preclinical and Clinical Learning Curve, Alexander von Gabain (Article)

PDF

VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques, W. Martin Kast (Article)

PDF

FluBlok, A High Dose Recombinant Hemagglutinin Influenza Vaccine, Manon Cox (Article)

PDF

Challenges and Solutions for the Next Generation of Vaccines: Development of Cell Culture-based Live Attenuated Influenza Vaccine, Jonathan Liu, Luis Maranga, Sachin Mani, and Richard Schwartz (Article)

PDF

Analytical and Manufacturing Challenges in Preparation of Bacterial Polysaccharide Conjugates, Carl Frasch (Article)

PDF

Development of Validated Assays for Measuring the Human Antibody Response to Polysaccharide Conjugate Vaccines, Helena Käyhty (Article)

PDF

Development of Vaxfectin®-adjuvanted DNA Vaccines, Alain Rolland (Article)

PDF

Well-Characterized Adenoviral Vector-Based Vaccines: Are We There Yet?, Katey Einterz Owen (Article)

PDF

Focus on Aggregation: Causes, Impact & Characterization, John Philo (Article)

PDF

RSV Vaccine Using Recombinant F protein?, Sophie Nallet (Article)

PDF

A Selective Recovery Methodology for the Primary Purification of Lipid Envelope Virus-Like Particles from S. cerevisiae, Gaik Sui Kee, Hari Pujar, and Nigel Titchener-Hooker (Article)

PDF

Trouble-Shooting Fermentation and Primary Recovery Manufacturing Issues in Order to Optimize Antigen Expression for the Vaccine Business, Tim Lee (Article)

PDF

Vaccine Development for Developing Countries – Regulatory Approach in the European Union, Manfred G. Haase (Article)

PDF

Developing Vaccines for Neglected Diseases, Douglas Holtzman (Article)

PDF

Challenge of Filing 4 New Vaccines at Once – Lessons Learned, Keith Chirgwin (Article)

PDF

Process Intensification for Large Scale Manufacturing Issues, J.C. Drugmand, N. Havelange, N. Alaoui, and J. Castillo (Article)

PDF

Emerging Diseases, Zoonoses and Vaccines to Control Them, Paul-Pierre Pastoret (Article)

PDF

Vaccine Technology II: Abstracts of Oral Presentations, The Editors (Article)

PDF

Vaccine Technology II: Abstracts of Poster Presentations, The Editors (Article)